April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Decrease in Hemoglobin As the Cause of Interferon-Induced Retinopathy
Author Affiliations & Notes
  • Meghan Berkenstock
    Ophthalmology, Drexel University College of Medicine, Philadelphia, PA
  • Francinia McCartney
    Ophthalmology, Drexel University College of Medicine, Philadelphia, PA
  • Jessica M Ackert
    Ophthalmology, Drexel University College of Medicine, Philadelphia, PA
  • Footnotes
    Commercial Relationships Meghan Berkenstock, None; Francinia McCartney, None; Jessica Ackert, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2881. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Meghan Berkenstock, Francinia McCartney, Jessica M Ackert; Decrease in Hemoglobin As the Cause of Interferon-Induced Retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2881.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

During chronic hepatitis C treatment with ribavirin and PEG INF, a subset of patients have been observed to develop interferon-induced retinopathy shortly after the diagnosis of anemia. Given the phenotypic overlap of both retinopathies, we examined if an association exists between the onset of anemia and the development of interferon-induced retinopathy in chronic hepatitis C patients receiving both ribavirin and PEG INF.

 
Methods
 

A retrospective case series study examined the electronic medical records of patients with Hepatitis C presenting since August of 2011. Any patient documented to initate interferon therapy were included in our analysis. All patients received a baseline eye screening prior to treatment initiation, and presented for routine ophthalmic re-examination during the course of their treatment. Any patient found to have intereferon- retinopathy undewent photographic documentation of these findings. We then compared patients who developed interferon retinopathy aganist the control group that did not develop retinopathy in an attempt to identify causative factors.

 
Results
 

Hemoglobin concentration levels between control and interferon-retinopathy patients tended to be slightly lower in the group that developed retinopathy, but here was no threshold hemoglobin concentration under which the rate of developing retinopathy increased. However, a greater than a 25% drop in hemoglobin was seen in patients who developed interferon retinopathy versus control subjects.

 
Conclusions
 

Patients with a greater than 25% reduction in hemoglobin during treatment with ribavirin and PEG INF should receive more frequent ophthalmic screening, as they are at an increased incidence of developing interferon-induced retinopathy. A larger cohort study is needed to delineate if a causal relationship between anemia and interferon-induced retinopathy exists, as the pathophysiology of fundus changes caused by each is poorly understood.

     
Keywords: 463 clinical (human) or epidemiologic studies: prevalence/incidence • 464 clinical (human) or epidemiologic studies: risk factor assessment • 572 ischemia  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×